| Parent Drug Name | Name of Impurity | Catalogue No. | |
|---|---|---|---|
| Dexlansoprazole | Dexlansoprazole Impurity 1 | VL4570001 | View |
| Dexlansoprazole | Dexlansoprazole Impurity 4 | VL4570002 | View |
| Dexlansoprazole | Dexlansoprazole Nitro Sulphoxide | VE008496 | View CAS 853950-77-3 |
| Catalogue No. | VE008496 |
| CAS No. | 853950-77-3 |
| Molecular Formula | C14H12N4O3S |
| Molecular Weight | 316.3 g/mol |
| Parent drug | Dexlansoprazole |
| IUPAC Name | (R)-2-(((3-methyl-4-nitropyridin-2-yl)methyl)sulfinyl)-1H-benzo[d]imidazole |
| Synonyms | N/A |
| References | Sci-Hub, A Baeyer-Villiger monooxygenase from Cupriavidus basilensis catalyzes asymmetric synthesis of (R)-lansoprazole and other pharmaco-sulfoxides. Applied Microbiology and Biotechnology, 105(8), 3169–3180, 10.1007/s00253-021-11230-0. (2021). Retrieved June 13, 2022, from Sci-hub.se website: https://sci-hub.se/https://doi.org/10.1007/s00253-021-11230-0 |
| Status | In-stock |
| ListName | Dexlansoprazole Nitro Sulphoxide |
| Exclusively Supplied by Veeprho | Exclusively Supplied by Veeprho |
"*" indicates required fields
